Advanced Medical Solutions Group PLC - Winsford-based surgical dressings company - Files pre-market approval application for LiquiBandFix8 which has been accepted by the US Food & Drug Administration. Expects US product approval at the end of 2023.
LiquiBandFix8 uses drops of cyanoacrylate adhesive instead of tacks to fix hernia mesh to tissue inside the body. AMS says the approval would be a ‘significant step forward’ for the treatment of hernias in the US.
Company adds it is evaluating a number of commercialisation strategies in the US for the product. The product is already being commercialised in Europe and other non-US markets.
Current stock price: 267.50 pence, down 0.2% in London on Monday
12-month change: down 17%
Copyright 2022 Alliance News Limited. All Rights Reserved.
